Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
28.9M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
+2.67M
-
Total reported value, excl. options
-
$327M
-
Value change
-
+$45.1M
-
Number of buys
-
42
-
Number of sells
-
-14
-
Price
-
$17.29
Significant Holders of LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) as of Q2 2024
73 filings reported holding LENZ - LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q2 2024.
LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 28.9M outstanding shares and own 65.52% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.18M shares), Alpha Wave Global, LP (3.61M shares), EcoR1 Capital, LLC (1.22M shares), Samsara BioCapital, LLC (1.21M shares), SECTORAL ASSET MANAGEMENT INC (1.08M shares), 72 Investment Holdings, LLC (1.02M shares), BlackRock Inc. (960K shares), VANGUARD GROUP INC (956K shares), Point72 Asset Management, L.P. (865K shares), and RTW INVESTMENTS, LP (863K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.